| Maternal human parvovirus B19 infection and the risk of fetal death and low birthweight: a case-control study within 35 940 pregnant women. | |
| | |
MedLine Citation:
|
PMID: 19769750 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: To assess the association between maternal parvovirus B19 infection and fetal death, birthweight and length of gestation. DESIGN: Case-control study. SETTING: Population based. POPULATION: Cases were all 281 women with fetal death within a cohort of 35 940 pregnant woxmen in Norway. The control group consisted of a random sample of 957 women with a live born child. METHOD: Information on pregnancy outcome was obtained from the Medical Birth Registry of Norway. First trimester serum samples were tested for antibodies against parvovirus B19 (IgM and IgG). In seronegative women, further serum was analysed to detect seroconversion during pregnancy. MAIN OUTCOME MEASURES: Fetal death, length of gestation and birthweight. RESULTS: Two of 281 (0.7%) of the women who experienced fetal death and nine of 957 (0.9%) of the controls had presence of IgM antibodies, crude odds ratio 0.8; 95% CI (0.2-3.5). In initially, seronegative women, 3.1% (2/65) with fetal death and 2.6% (8/307) with a live birth seroconverted, crude odds ratio 1.2; 95% CI (0.2-5.7). Presence of maternal parvovirus-specific IgG or IgM antibodies in the first trimester, or seroconversion during pregnancy were not associated with lower birthweight or reduced length of gestation in live born children, but was associated with low birthweight in stillborn offspring. CONCLUSION: Maternal parvovirus B19 infection was not associated with fetal death in our study. Very few cases of fetal death may be attributed to maternal parvovirus B19 infection. |
| | |
Authors:
|
A A Sarfraz; S O Samuelsen; A-L Bruu; P A Jenum; A Eskild |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: BJOG : an international journal of obstetrics and gynaecology Volume: 116 ISSN: 1471-0528 ISO Abbreviation: BJOG Publication Date: 2009 Oct |
Date Detail:
|
Created Date: 2009-09-22 Completed Date: 2010-02-16 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100935741 Medline TA: BJOG Country: England |
Other Details:
|
Languages: eng Pagination: 1492-8 Citation Subset: AIM; IM |
Affiliation:
|
Department of Gynecology and Obstetrics and Medical Faculty Division, Akershus University Hospital, L?renskog, Norway. ashi@broadpark.no |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Case-Control Studies Female Fetal Death / virology* Gestational Age Humans Immunoglobulin G / blood Immunoglobulin M / blood Infant, Low Birth Weight Infant, Newborn Middle Aged Norway Parvoviridae Infections / virology* Parvovirus B19, Human* / immunology Pregnancy Pregnancy Complications, Infectious / virology* Pregnancy Trimester, First Prospective Studies Risk Factors Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Immunoglobulin G; 0/Immunoglobulin M |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Induced termination of pregnancy and low birthweight and preterm birth: a systematic review and meta...
Next Document: A new transcutaneous energy transmission system with hybrid energy coils for driving an implantable ...